The table records clinical developments using data from Informa Pharma Intelligence’s Biomedtracker. It lists drugs for which an important event was recorded between Jan. 13 and Jan. 19, 2017, divided
IN VITRO DIAGNOSTICS Mergers & Acquisitions Abingdon Health Ltd. Molecular Vision Ltd. Abingdon Health Ltd. has purchased a 50.1% equity stake in fellow private diagnostics firm Molecular Vision